Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients
Sponsor: University of Padova
Summary
This clinical trial aims to learn if the probiotic Prolife 10 Forte could improve the Gut Microbiota composition of Ulcerative colitis patients during the remission phase. The main questions it seeks to answer are: * Does Prolife 10 Forte improve the microbiota composition in patients with Ulcerative colitis? * Is it possible to highlight the variation in microbial pathways? * What clinical parameters vary and are associated with changes in the gut microbiota? Researchers will compare Prolife 10 Forte to a placebo (a look-alike substance containing no drug) to see if the probiotics improve microbiota. Participants will: * Take 1 vial/day of Prolife 10 Forte /Placebo for 60 days. * Visit the clinic two times for checkups, Questionaire and tests
Official title: Evaluation of the Effects of 10-strain Probiotic (ProLife 10 FORTE) on Gut Microbiota Composition in Patients Presenting with Ulcerative Colitis During the Remission Phase
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2024-05-15
Completion Date
2026-06-15
Last Updated
2024-10-15
Healthy Volunteers
No
Conditions
Interventions
Prolife
randomized in a 1:1 ratio to treatment :1 vial/day for 60 days.
Placebo
Placebo: 1 vial/day for 60 days.
Locations (1)
Edoardo Vincenzo Savarino
Padua, Padua, Italy